Last update 20 Mar 2025

Shufeng Zhike Granules

Overview

Basic Info

Drug Type
Herbal medicine
Synonyms-
Target-
Action-
Mechanism-
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesImmune System Diseases
Active Indication
Acute onset coughCommon ColdCough variant asthma
Inactive Indication-
Originator Organization
Beijing Zhongyan Tongrentang Pharmaceutical R&D Co., Ltd.Beijing Zhongyan Tongrentang Pharmaceutical R&D Co., Ltd.
Active Organization
Beijing Zhongyan Tongrentang Pharmaceutical R&D Co., Ltd.Beijing Zhongyan Tongrentang Pharmaceutical R&D Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with Shufeng Zhike Granules
ITMCTR2024000307
/ RecruitingNot ApplicableIIT
Randomized controlled study of Shufeng Zhike prescription in the treatment of cough with wind cough syndrome after pulmonary resection
CTR20192604
/ RecruitingPhase 2
疏风止咳颗粒治疗咳嗽变异性哮喘的随机、双盲、安慰剂平行对照、剂量探索、多中心Ⅱa期临床试验
[Translation] A randomized, double-blind, placebo-controlled, dose-finding, multicenter phase IIa clinical trial of Shufeng Zhike granules in the treatment of cough variant asthma
100 Clinical Results associated with Shufeng Zhike Granules
Login to view more data
100 Translational Medicine associated with Shufeng Zhike Granules
Login to view more data
100 Patents (Medical) associated with Shufeng Zhike Granules
Login to view more data
100 Deals associated with Shufeng Zhike Granules
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Acute onset coughPhase 3
China
Tasly Pharmaceutical Group Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.
01 Feb 2025
Common ColdPhase 3
China
Tasly Pharmaceutical Group Co., Ltd.Tasly Pharmaceutical Group Co., Ltd.
01 Feb 2025
Cough variant asthmaPhase 2
China
Beijing Zhongyan Tongrentang Pharmaceutical R&D Co., Ltd.Beijing Zhongyan Tongrentang Pharmaceutical R&D Co., Ltd.
29 Aug 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free